Chia Tai Tianqing Pharmaceutical Group (CTTQ)

Response Research to Emerging Infectious Diseases Inform

March 26, 2024

Skin Type Before Choosing Skin Care Products

March 26, 2024

Using Lemon on Your Face & Ways to

March 26, 2024

Most Common Exercise Machines at the Gym

March 26, 2024

Contact Info

E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com

Tag: Chia Tai Tianqing Pharmaceutical Group (CTTQ)

Cipla, CTTQ Partner to Develop and Commercialise HER2 ADC in Emerging Markets

News

Cipla, SBP Group Sign Exclusive Licensing Agreement for HER2 Bispecific ADC

Under the partnership, Cipla will receive exclusive rights to develop and commercialise TQB2102 in India, South Africa and five other emerging markets.

imphoenix82
August 31, 2026
0 Comments
113 Views

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Email: support@healthxploreindia.com

Contact: +91 9354115542

Response Research to Emerging Infectious Diseases Inform

Skin Type Before Choosing Skin Care Products

Using Lemon on Your Face & Ways to

Most Common Exercise Machines at the Gym

Contact Info

Tag: Chia Tai Tianqing Pharmaceutical Group (CTTQ)

Cipla, SBP Group Sign Exclusive Licensing Agreement for HER2 Bispecific ADC

Cipla, SBP Group Sign Exclusive Licensing Agreement for.

Lilly to Acquire Merida Biosciences for Up to.

BIS to Host Seminar on Medical Device Packaging.

Repatha Cuts Death Risk by 20% in High-Risk.

About Us

Quick Link

Top Categories

Top Posts

Laser Treatments for Anti-aging: Types, Benefits,

Lilly’s Retatrutide Shows Powerful Weight Loss

National Registry for Implantable Medical Devices: